share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

Chardan Capital Maintains Buy on Coya Therapeutics, Maintains $14 Price Target

Chardan Capital维持对Coya Therapeutics的买入,维持14美元的目标股价
Benzinga ·  04/29 08:05

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and maintains $14 price target.

Chardan Capital分析师Keay Nakae维持Coya Therapeutics(纳斯达克股票代码:COYA)的买入并维持14美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发